President Donald J. Trump just released his second executive order (EO) addressing high prescription drug prices. This is ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance generating revenues with ensuring that a new medicine reaches the largest possible ...

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

The Council is now set to begin negotiations with the European Parliament on the package, after which the rules would be ...

During an FDA panel discussion, the US health secretary prioritised easier routes to market for curative therapies.

Major medtech companies are preparing for significant financial headwinds as tariffs threaten to disrupt the $200 billion | ...

The private equity major picks up minority stake in Ireland's Felix Pharma, betting on fast-growing global market for generic ...